Pediatric Off-Label Covid-19 Vaccine Use

IPPP members Shannon Fyfe and Elizabeth Lanphier recently argued that pediatric off-label use of the Covid-19 should not be prohibited in articles published in Hastings Center Report and The Conversation.

"Our research suggests that although off-label vaccination is not a public health solution to increasing access to Covid-19 vaccines for all kids, it should be an ethically and legally permissible solution available to at least some kids, especially those at high risk of complications from Covid-19."